Detalles de la búsqueda
1.
Elucidation of the Application of Blood Test Biomarkers to Predict Immune-Related Adverse Events in Atezolizumab-Treated NSCLC Patients Using Machine Learning Methods.
Front Immunol
; 13: 862752, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35844547
2.
Definition of a new blood cell count score for early survival prediction for non-small cell lung cancer patients treated with atezolizumab: Integrated analysis of four multicenter clinical trials.
Front Immunol
; 13: 961926, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36119066
Resultados
1 -
2
de 2
1
Próxima >
>>